Zealand Pharma — Maj 2025
-
We are incredibly excited to launch this partnership, which represents a step change to realize Zealand Pharma’s vision of becoming a key player in the future management of obesity. Roche ticked all the right boxes for what we were looking for in a partner and we look very much forward to working closely together to unlock the full potential of petrelintide to benefit people who are overweight or obese”, said Adam Steensberg, Chief Executive Officer at Zealand Pharma.
-
Zealand Pharma får sænket sit kursmål til 780 kr. fra 850 kr. af svenske SEB https://proinvestor.com/investornyt/1314687/zealand-pharma-far-saenket-sit-kursmal-til-780-kr-fra-850-kr-af-svenske-seb
-
Zealands kursmål skåret 8 pct. af Goldcman Sachs https://proinvestor.com/investornyt/1314691/zealands-kursmal-skaret-8-pct-af-goldcman-sachs
-
OVERBLIK: Disse selskaber er shortet på det danske aktiemarked https://proinvestor.com/investornyt/1314702/overblik-disse-selskaber-er-shortet-pa-det-danske-aktiemarked
-
Spørgsmål til Q&A er meget velkommen.
-
Novo Nordisk, Eli Lilly, life science: Derfor steg aktierne på trods af nye tiltag https://proinvestor.com/boards/126340
-
Novo og Zealand kan se GSK købe middel mod fedtlever for milliardbeløb https://proinvestor.com/investornyt/1316852/novo-og-zealand-kan-se-gsk-kobe-middel-mod-fedtlever-for-milliardbelob
-
Spørgsmål til Q&A d. 20/5 er stadig meget velkommen.
-
C25-regnskaber, 1. kvartal 2025: Karakterbogen https://proinvestor.com/boards/126363
-
Sundhedsaktierne i USA fortsatte nedturen - ikke længere sikker havn https://proinvestor.com/investornyt/1317372/sundhedsaktierne-i-usa-fortsatte-nedturen-ikke-laengere-sikker-havn
-
OVERBLIK: Disse selskaber er shortet på det danske aktiemarked https://proinvestor.com/investornyt/1317380/overblik-disse-selskaber-er-shortet-pa-det-danske-aktiemarked
-
Pharma-aktier er typisk dem, investorer regner for en sikker havn i urolige tider. Men ikke engang dén sektor er fredet længere, hvor Trump kommer med udmeldinger om told og store prissænkninger på medicin i USA. Hvad kan vi som investorer se frem mod? Hvornår slutter dette mareridt? Det giver Helge Larsen sit bud på. Herudover omtales Lundbecks flotte regnskab og Genmabs udsigt til evt. lidt mindre royalty på Darzalex i 2029. https://proinvestor.com/boards/126377
-
****ZEALAND PHARMA/DEUTSCHE BANK: KURSMÅL SÆNKES TIL 485 KR. FRA 750 KR.
-
Zealand Pharma udpeger Steven Johnson som chef for udvikling https://proinvestor.com/investornyt/1318984/zealand-pharma-udpeger-steven-johnson-som-chef-for-udvikling
-
Q&A er afsluttet. Tusinde tak til alle for de skarpe spørgsmål.
-
Transcript fra Proinvestors Q&A med CEO Adam Steensberg fra Zealand Pharma tirsdag d. 20. maj 2025
Moderator: Redaktør Helge Larsen https://nbg1.your-objectstorage.com/proinvestor-dev/forum/ir/cms/QA-Zealand Pharma 2025-05-20.pdf -
OVERBLIK: Disse selskaber er shortet på det danske aktiemarked https://proinvestor.com/investornyt/1319883/overblik-disse-selskaber-er-shortet-pa-det-danske-aktiemarked
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind